Page last updated: 2024-10-23

bethanechol and Cancer of Pancreas

bethanechol has been researched along with Cancer of Pancreas in 2 studies

Bethanechol: A slowly hydrolyzing muscarinic agonist with no nicotinic effects. Bethanechol is generally used to increase smooth muscle tone, as in the GI tract following abdominal surgery or in urinary retention in the absence of obstruction. It may cause hypotension, HEART RATE changes, and BRONCHIAL SPASM.
bethanechol : The carbamic acid ester of 2-methylcholine. A slowly hydrolysed muscarinic agonist with no nicotinic effects, it is used as its chloride salt to increase smooth muscle tone, as in the gastrointestinal tract following abdominal surgery, treatment of gastro-oesophageal reflux disease, and as an alternative to catheterisation in the treatment of non-obstructive urinary retention.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's1 (50.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Pour, PM1
Donnelly, T1
Stepan, K1
al-Laith, M1
Matthews, EK1

Other Studies

2 other studies available for bethanechol and Cancer of Pancreas

ArticleYear
Modification of pancreatic carcinogenesis in the hamster model. 7. Inhibitory effect of bethanechol chloride.
    The American journal of pathology, 1983, Volume: 112, Issue:2

    Topics: Animals; Bethanechol; Bethanechol Compounds; Carcinoma in Situ; Cricetinae; Female; Male; Mesocricet

1983
Calcium-dependent photodynamic action of di- and tetrasulphonated aluminium phthalocyanine on normal and tumour-derived rat pancreatic exocrine cells.
    British journal of cancer, 1994, Volume: 70, Issue:5

    Topics: Amylases; Animals; Antimycin A; Bethanechol; Calcium; Carcinoma, Acinar Cell; Deoxyglucose; Egtazic

1994